Off Label, On Agenda: Gabapentin’s Rise and the Debauchery Behind It
From The Highwire
Gabapentin’s surge exposes a profit-first system where off-label prescribing, not patient care, drives one of America’s top drugs.
Oct 28th 2025 6:38am EDT
Source Link: https://thehighwire.com/editorial/off-label-on-agenda-gabapentins-rise-and-the-debauchery-behind-it/
Share, promote & comment with Nostr: https://dissentwatch.com/boost/?boost_post_id=1055707